Form PX14A6G - Notice of exempt solicitation submitted by non-management:
SEC Accession No. 0001816079-23-000004
Filing Date
2023-10-17
Accepted
2023-10-17 12:28:32
Documents
1
Effectiveness Date
2023-10-17

Document Format Files

Seq Description Document Type Size
1 SHAREHOLDER JERALD HAMMANN DISCONTINUES DMK PHARMACEUTICALS CORP. PROXY CONTEST PX14A6G887247820429727231017.htm PX14A6G 10715
  Complete submission text file 0001816079-23-000004.txt   12209
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
DMK PHARMACEUTICALS Corp (Subject) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PX14A6G | Act: 34 | File No.: 001-36242 | Film No.: 231329068
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1566 SUMTER AVE N MINNEAPOLIS MN 55427-4048
Business Address
Hammann Jerald (Filed by) CIK: 0001816079 (see all company filings)

Type: PX14A6G